Kiora Pharmaceuticals, Inc. (KPRX)
2.29
-0.03
(-1.29%)
USD |
NASDAQ |
Oct 23, 16:00
2.29
0.00 (0.00%)
After-Hours: 20:00
Kiora Pharmaceuticals Net Income (Quarterly) : -2.079M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.079M |
| March 31, 2026 | -2.418M |
| December 31, 2025 | -6.516M |
| September 30, 2025 | 0.0268M |
| June 30, 2025 | -2.152M |
| March 31, 2025 | -2.193M |
| December 31, 2024 | -4.224M |
| September 30, 2024 | -3.413M |
| June 30, 2024 | -2.222M |
| March 31, 2024 | 13.45M |
| December 31, 2023 | -2.269M |
| September 30, 2023 | -5.763M |
| June 30, 2023 | -2.614M |
| March 31, 2023 | -1.868M |
| December 31, 2022 | -2.498M |
| September 30, 2022 | -5.119M |
| June 30, 2022 | -2.401M |
| March 31, 2022 | -3.565M |
| December 31, 2021 | -5.754M |
| September 30, 2021 | -3.035M |
| June 30, 2021 | -2.543M |
| March 31, 2021 | -2.011M |
| December 31, 2020 | -1.186M |
| September 30, 2020 | -2.007M |
| June 30, 2020 | -1.717M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.952M |
| December 31, 2019 | -2.702M |
| September 30, 2019 | -3.428M |
| June 30, 2019 | -1.837M |
| March 31, 2019 | 0.8708M |
| December 31, 2018 | -2.528M |
| September 30, 2018 | -3.124M |
| June 30, 2018 | -2.780M |
| March 31, 2018 | -2.379M |
| December 31, 2017 | -2.831M |
| September 30, 2017 | -4.140M |
| June 30, 2017 | -3.327M |
| March 31, 2017 | -2.920M |
| December 31, 2016 | -3.701M |
| September 30, 2016 | -3.377M |
| June 30, 2016 | -3.823M |
| March 31, 2016 | -2.442M |
| December 31, 2015 | -2.69M |
| September 30, 2015 | -1.356M |
| June 30, 2015 | -1.541M |
| March 31, 2015 | -2.801M |
| December 31, 2014 | -0.3519M |
| September 30, 2014 | 0.3503M |
| June 30, 2014 | -0.6469M |
| March 31, 2014 | -0.9029M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.079M |
| EPS Diluted (Quarterly) | -0.3365 |
| Enterprise Value | -6.367M |
| Earnings Yield | -115.4% |
| Normalized Earnings Yield | -88.90 |